GlycoMimetics
GlycoMimetics is a Maryland-based clinical-stage biotechnology company that develops and commercializes glycobiology therapies for cancer and inflammatory diseases.
Business Model:
Revenue: $92.6k
Employees: 11-50
Rankings
Industries / Tags:
Detailed GlycoMimetics Information
Geographic Data
Address: 9708 Medical Center Drive
City: Rockville
State: MD
Zip: 20850
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$93M
Raised Total:$120M
Social
Metrics
7,602,577Website Global Rank
484Website Monthly Traffic
Twitter Followers
Description
GlycoMimetics is a Maryland-based clinical-stage biotechnology company that develops and commercializes glycobiology therapies for cancer and inflammatory diseases.
Contact Phone:
+12402431201
Contact Email:
GlycoMimetics went public on 1/10/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/10/2014
Ticker Symbol:
GLYC
IPO Price:
$8/share
Amount Raised:
$56M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
